PedAM
Pediatric Disease Annotations & Medicines
| Disease | gastroesophageal reflux disease |
| Symptom | C0267055|erosive esophagitis |
| Sentences | 2 |
| PubMedID- 22832034 | Intravenous esomeprazole is approved in the united states for the short-term treatment of gastroesophageal reflux disease (gerd) with erosive esophagitis in adults and in pediatric patients 1 month to 17 years of age (inclusive) as an alternative to oral therapy. |
| PubMedID- 23476803 | Pantoprazole, a proton pump inhibitor (ppi), is indicated for the treatment of erosive esophagitis associated with gastroesophageal reflux disease (gerd). |
Page: 1